Amgen - Statistics & Facts

Biotechnology company Amgen was originally founded as AMGen in 1980, standing for Applied Molecular Genetics. The company is headquartered in Thousand Oaks, California, but has establishments in many other countries around the world. Today, Amgen is one of the world’s largest pure play biotechnology companies, generating more than billion U.S. dollars of revenue and employing over 21 thousand people worldwide.

Amgen is among the global top 10 pharmaceutical companies based on market value. As of August 2019, the company was worth some 115 billion U.S. dollars. Biopharmaceuticals manufactured by Amgen are also among the leading biotech drugs worldwide. Enbrel and Neulasta are the company’s flagship products, responsible for over one third of Amgen’s total revenue. Interestingly, Amgen generates almost three quarters of its revenues on the domestic U.S. market.

As is common in the biopharmaceutical industry, Amgen spends a significant proportion of its income on research and development. In 2019, Amgen spent nearly 18 percent of its revenue on R&D purposes. Some 26 percent of 4.12 billion dollars of R&D spending was for late-stage clinical programs, while the rest was for discovery research and for marketed products.

Interesting statistics

In the following 5 chapters, you will quickly find the 22 most important statistics relating to "Amgen".

Amgen

Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!
TOP SELLER

Important key figures

The most important key figures provide you with a compact summary of the topic of "Amgen" and take you straight to the corresponding statistics.

Company key facts

Select expenses

Any more questions?

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.